{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "6388249",
  "DateCompleted": {
    "Year": "1984",
    "Month": "12",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "08",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0001-690X",
      "JournalIssue": {
        "Volume": "70",
        "Issue": "4",
        "PubDate": {
          "Year": "1984",
          "Month": "Oct"
        }
      },
      "Title": "Acta psychiatrica Scandinavica",
      "ISOAbbreviation": "Acta Psychiatr Scand"
    },
    "ArticleTitle": "Clinical investigations into antidepressive mechanisms. II. Dexamethasone suppression test predicts response to nomifensine or amitriptyline.",
    "Pagination": {
      "StartPage": "342",
      "EndPage": "353",
      "MedlinePgn": "342-53"
    },
    "Abstract": {
      "AbstractText": [
        "This prospective study investigates the possibility of a central noradrenergic-cholinergic imbalance in subgroups of depressed inpatients using the dexamethasone suppression test (DST) as one peripheral indicator. The DST was performed in 43 depressed inpatients. Subsequently, a group (n = 20) of DST suppressors (DST-) and a group (n = 23) of DST nonsuppressors (DST+) were treated under double blind conditions with either nomifensine (NOM) a noradrenaline potentiating drug, or amitriptyline (AMI) a noradrenaline potentiating and strong anticholinergic compound. DST+ depressives responded favorably to AMI, but not to NOM. Conversely, DST- depressives responded favorably to NOM but less well to AMI. Together with other biochemical findings this data suggests: 1) a hypofunction of the noradrenergic system in DST- patients who may, from a clinical point of view, usually show minor or 'neurotic' depressions; 2) a hypofunction of the noradrenergic and a hyperfunction of the cholinergic system in DST+ patients who may present a more severe or 'endogenous' depression. These data suggest a biochemical heterogeneity of depression and offer an aid for a more specific antidepressive drug therapy."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Beckmann",
        "ForeName": "H",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Holzm\u00fcller",
        "ForeName": "B",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Fleckenstein",
        "ForeName": "P",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Acta Psychiatr Scand",
    "NlmUniqueID": "0370364",
    "ISSNLinking": "0001-690X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Isoquinolines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, Cholinergic"
    },
    {
      "RegistryNumber": "1806D8D52K",
      "NameOfSubstance": "Amitriptyline"
    },
    {
      "RegistryNumber": "1LGS5JRP31",
      "NameOfSubstance": "Nomifensine"
    },
    {
      "RegistryNumber": "7S5I7G3JQL",
      "NameOfSubstance": "Dexamethasone"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Amitriptyline"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Bipolar Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Clinical Trials as Topic"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Dexamethasone"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Double-Blind Method"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Isoquinolines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Nomifensine"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Receptors, Cholinergic"
    }
  ]
}